Byhealth Co., Ltd (SHE:300146)

Market Cap	16.37B -11.8%
Revenue (ttm)	6.34B +6.0%
Net Income	729.32M +91.5%
EPS	0.44 +97.8%
Shares Out	1.68B
PE Ratio	22.26
Forward PE	20.02
Dividend	0.45 (4.62%)
Ex-Dividend Date	Apr 21, 2026

Volume	10,388,653
Open	10.00
Previous Close	9.77
Day's Range	9.58 - 10.00
52-Week Range	9.59 - 13.20
Beta	0.49
Analysts	Strong Buy
Price Target	12.85 (+31.53%)
Earnings Date	Aug 7, 2026

About Byhealth

Byhealth Co., Ltd, together with its subsidiaries, provides dietary supplements in China, Hong Kong, Australia, and internationally. It offers protein powder; collagen; bone health products, including glucosamine, chondroitin, and calcium tablets; probiotics; capsules; and multivitamins under the By-Health, Jianlidu, LifeSpace, and other brand names. The company also engages in scenic area tourism management; real estate; trade and investment; sale of food; trademark management; and OTC licensing and outsourced processing activities. It sells i...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1995
• Employees: 2,867
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300146

Financial Performance

In 2025, Byhealth's revenue was 6.27 billion, a decrease of -8.38% compared to the previous year's 6.84 billion. Earnings were 782.15 million, an increase of 19.81%.